An insight overview on COVID-19 mRNA vaccines: advantageous, pharmacology, mechanism of action, and prospective considerations
The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has urged scientists to present some novel vaccine platforms during this pandemic to …
has urged scientists to present some novel vaccine platforms during this pandemic to …
[HTML][HTML] Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art
N Ivanov, B Krastev, DG Miteva… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Although the coronavirus disease 2019 (COVID-19) pandemic was declared to be no longer
“a public health emergency of international concern” with its wide range of clinical …
“a public health emergency of international concern” with its wide range of clinical …
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
Objectives The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to
assess short-term COVID-19 vaccination-related adverse events (AEs) in RA patients …
assess short-term COVID-19 vaccination-related adverse events (AEs) in RA patients …
Increasing autoimmune rheumatic diseases as a consequence of the COVID‐19 pandemic: A hypothesis or fact?
C Baimukhamedov, G Togizbayev… - International …, 2024 - search.ebscohost.com
The COVID-19 pandemic caused by the SARS-CoV-2 virus has had a significant impact on
the global population's health. The true extent of the pandemic's consequences is difficult to …
the global population's health. The true extent of the pandemic's consequences is difficult to …
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
P Sen, N Houshmand, S Moghadam Kia, M Joshi… - …, 2023 - academic.oup.com
Objective COVID-19 vaccines have a favorable safety profile in patients with autoimmune
rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however …
rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however …
Autoimmune disorders reported following COVID-19 vaccination: a disproportionality analysis using the WHO database
Purpose Owing to adverse event following immunization (AEFI) related to autoimmune
disorders and coronavirus disease 2019 (COVID-19) vaccines sharing common biological …
disorders and coronavirus disease 2019 (COVID-19) vaccines sharing common biological …
[HTML][HTML] Safety and reported adverse effects of coronavirus disease-2019 (COVID-19) vaccines in patients with rheumatic diseases
FM Aboud, RS Hussein, RM Hassan - The Egyptian Rheumatologist, 2023 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms and severity of COVID19 are …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms and severity of COVID19 are …
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys
P Sen, R Naveen, N Houshmand… - …, 2023 - eprints.whiterose.ac.uk
Objective COVID-19 vaccines have a favorable safety profile in patients with autoimmune
rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs), however …
rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs), however …
Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study
T Chatterjee, N Ravichandran, N Nair… - Journal of diabetes …, 2024 - Wiley Online Library
Abstract Aims/Introduction Coronavirus disease 2019 (COVID‐19) vaccinations have been
proven to be generally safe in healthy populations. However, the data on vaccine safety in …
proven to be generally safe in healthy populations. However, the data on vaccine safety in …
Social media for research discourse, dissemination, and collaboration in rheumatology
Social media has become an important venue for rheumatologists, patients, organizations,
and other stakeholders to discuss recent research advances in diagnosis and management …
and other stakeholders to discuss recent research advances in diagnosis and management …